Press Room

Rui Loureiro speaker at The Scale Up of Chemical Processes Conference

Start
Wednesday, June 21, 2017 - 00:00
End
Wednesday, June 21, 2017 - 00:00
Location: New York, United States

Rui Loureiro is guest speaker at The Scale-Up of Chemical Processes
Date: 22 June
Time: 9:15 AM

The Scale-Up of Chemical Processes is one of the major international forums for the discussion of interesting aspects of scale-up in the pharmaceutical, fine chemical and allied fields. This broad-based conference is the best place to discuss the latest ideas and techniques with the key people in the industry presenting case studies and examples of some of the pitfalls and problems they encountered and how they overcame them.

Topics

  • Achieving greater process efficiency, yield and throughput
  • Eliminating unsafe and non-green processes and materials
  • Decreasing the costs and number of steps involved

Also in the Press Room

See All

Continuous Tableting (CT) is defined as continuous manufacturing of oral dose drugs, specifically tablets. As per ICH's Q13 definition1, a continuous manufacturing process in the pharmaceutical industry comprises at least two unit operations integrated from a mechanical and software perspective. There is a wide combination of possible CT process configurations that are dependent on the needs of the intended product formulation and each of the individual unit operations that constitute the process train can be continuous, semi-continuous, or batch processes. The typical manufacturing processes for tablet formulation are direct compression (DC), dry granulation (DG) and wet granulation (WG)2 - details on these manufacturing processes are beyond the scope of this article, so the interested reader is directed to relevant literature. The actual implementation of CT technology in a facility can broadly vary depending on the level of desired integration and automation. Process trains can be designed to be flexible and converted between multiple configurations (e.g. continuous DC, DG and WG), controlled by the end user from one single software and within a single clean room. The other possibility would be for subsections of the CT process to be divided into multiple clean rooms where inprocess materials are transferred between suites via a bin-to-bin approach (e.g. a granulation suite to prepare granules from raw materials followed by continuous DC (CDC) to blend the granules and produce tablets). The level of automation and instrumentation designed into the CT process (typically involving Process Analytical Technologies, PAT) can open the possibility to implement sophisticated control strategies. Key components of a control strategy that need to be considered for CT are material tracking and genealogy, knowledge of the residence time distribution (RTD), and in-process controls (spectroscopic and/or soft sensors based on process parameters). Holistically, these control strategy elements enable the implementation of a material diversion strategy to automatically divert out of specification material from the process. In their most advanced form, control strategies may also enable real time release testing (RTRt) of the final tablet drug product and reduce the off-line analytical burden and the number of operators needed to manage the process.   Read the full article at gmp-journal.com  

Article

Continuous Tableting and the Road to Global Adoption

Mar 04, 2024